Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy

HIV Medicine

Volumn 15, Issue 3, 2014, Pages 153-164

  Ndumbi, P ^a   Gillis, J ^b   Raboud, Janet ^b,c   Cooper, Curtis ^l   Hogg, Robert ^e   Montaner, Julio ^g   Burchell, An ^c,h   Loutfy, Mona ^c   Machouf, Nima ^p   Klein, Marina ^o   Tsoukas, Chris ^m   Aykroyd, Gloria ^h   Balfour, Louise ^l   Cairney, John ^c   Calzavara, Liviana ^c   Gough, Kevin ^c   Millson, Peggy ^c   Rachlis, Anita ^c   Read, Stanley ^c   Salit, Irving ^c   Walmsley, Sharon ^c   Gardner, Sandra ^c   Bayoumi, Ahmed ^c   Cescon, Angela ^f   Guillemi, Silvia ^g   Harrigan, P Richard ^g   Harris, Marianne ^f   Hatzakis, George ^m   Hosein, Sean ⁿ   Kilby, Don ^l   Rourke, Sean ^l   Lalonde, Richard ^o   Limak, Viviane ^g   Mills, Ed ^l   Moore, David ^g   Palmer, Alexis ^f   Smieja, Marek ^q   Taylor, Darien ⁿ   Trottier, Benoit ^p   Wobeser, Wendy ^r   Fisher, Mark ^h   Rueda, Sergio ^h   Gataric, Nada ^f   Colley, Guillaume ^f   Yip, Benita ^f   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e SIMON FRASER UNIVERSITY   (Canada)

^f BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h ONTARIO HIV TREATMENT NETWORK   (Canada)

ⁱ Centre for Research in Women's Health   (Canada)

^j MAPLE LEAF MEDICAL CLINIC   (Canada)

^k Clinique Medicale l'Actuel   (Canada)

^l UNIVERSITY OF OTTAWA   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ Canadian AIDS Treatment Information Exchange   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p UNIVERSITÉ DE MONTRÉAL   (Canada)

^q MCMASTER UNIVERSITY   (Canada)

^r QUEEN S UNIVERSITY   (Canada)

more..

Author keywords

Antiretroviral therapy; Canadian Observational Cohort (CANOC); HIV; Immune dysregulation; Immune recovery; T cell homeostasis

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR;

ANTIVIRAL THERAPY; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; FEMALE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

ANTIRETROVIRAL THERAPY; CANADIAN OBSERVATIONAL COHORT (CANOC); HIV; IMMUNE DYSREGULATION; IMMUNE RECOVERY; T-CELL HOMEOSTASIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANADA; CD4-CD8 RATIO; HIV INFECTIONS; HIV-1; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; T-LYMPHOCYTES; VIRAL LOAD;

EID: 84893733635     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12096     Document Type: Article

References (48)

1. Lalioti MD, Zhang J, Volkman HM etal. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124-1132.
2. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1[alpha] and SIRT1. Nature 2005; 434: 113-118.
3. Douek DC, Betts MR, Hill BJ etal. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 2001; 167: 6663-6668.
4. Mackall CL, Fleisher TA, Brown MR etal. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
5. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1: 426-432.
6. Fahey JL, Prince H, Weaver M. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med 1984; 76: 95-100.
7. Gottlieb MS, Schroff R, Schanker HM etal. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 1981; 305: 1425-1431.
8. Margolick JB, Donnenberg AD, Muñoz A etal. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- Populations suggest regulatory responses linked to loss of CD4 lymphocytes. J Acquir Immune Defic Syndr 1993; 6: 153-161.
9. Adleman LM, Wofsy D. T-cell homeostasis: implications in HIV infection. J Acquir Immune Defic Syndr 1993; 6: 144-152.
10. Brunvand MW, Collins C, Livingston RB, Raghu G. Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma. Cancer 1991; 67: 2407-2409.
11. Khoruts A, Fraser JM. A causal link between lymphopenia and autoimmunity. Immunol Lett 2005; 98: 23-31.
12. Zolla-Pazner S, Des Jarlais DC, Friedman SR etal. Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A 1987; 84: 5404-5408.
13. Althoff KN, Justice AC, Gange SJ etal. Virologic and immunologic response to HAART, by age and regimen class. AIDS 2010; 24: 2469-2479.
14. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000; 97: 9203-9208.
15. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J. Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 2005; 77: 141-150.
16. Wu YE, Zhang SW, Peng WG etal. Changes in lymphocyte subsets in the peripheral blood of patients with active pulmonary tuberculosis. J Int Med Res 2009; 37: 1742-1749.
17. Malphettes M, Gerard L, Carmagnat M etal. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009; 49: 1329-1338.
18. Palella FJ, Jr, Baker RK, Moorman AC etal. Mortality in the Highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
19. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 1995; 50: B378-B382.
20. Strindhall J, Skog M, Ernerudh J etal. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 2013; 35: 985-991.
21. Kaufman HS, Kvitash VI. Immunologic abnormalities associated with acute ischemic heart disease (a pilot study). Ann Allergy 1989; 63: 287-290.
22. Lo J, Abbara S, Shturman L etal. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010; 24: 243-253.
23. Palmer AK, Klein MB, Raboud J etal. Cohort profile: the Canadian Observational Cohort collaboration. Int J Epidemiol 2011; 40: 25-32.
24. Kaufmann GR, Furrer H, Ledergerber B etal. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin Infect Dis 2005; 41: 361-372.
25. Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB, for the Canadian Co-infection Cohort Study I. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. AIDS 2010; 24: 1857-1865.
26. CDC. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-730.
27. Raboud JM, Loutfy MR, Su D etal. Regional differences in rates of HIV-1 viral load monitoring in Canada: insights and implications for antiretroviral care in high income countries. BMC Infect Dis 2010; 10: 40.
28. Rajasuriar R, Gouillou M, Spelman T etal. Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV observational database. PLoS ONE 2012; 6: e20713.
29. The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research Europe. CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med 2012; 9: e1001194.
30. Adleman LM, Wofsy D. Blind T-cell homeostasis in CD4-deficient mice. J Acquir Immune Defic Syndr 1996; 11: 334-340.
31. Rahemtulla A, Fung-Leung WP, Schilham MW etal. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991; 353: 180-184.
32. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3: 144-151.
33. Shete A, Thakar M, Abraham PR, Paranjape R. A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians. Indian J Med Res 2010; 132: 667-675.
34. Bofill M, Janossy G, Lee CA etal. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992; 88: 243-252.
35. Carmichael KF, Abayomi A. Analysis of diurnal variation of lymphocyte subsets in healthy subjects in the Caribbean, and its implication in HIV monitoring and treatment. Afr J Med Med Sci 2006; 35: 53-57.
36. Margolick JB, Munoz A, Donnenberg AD etal. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nat Med 1995; 1: 674-680.
37. Hatzakis GE, Tsoukas CM. Neural networks morbidity and mortality modeling during loss of HIV T-cell homeostasis. Proc AMIA Symp 2002; 320-324.
38. Vila LM, Alarcon GS, McGwin G, Jr, Bastian HM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006; 55: 799-806.
39. Duszczyszyn DA, Beck JD, Antel J etal. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin Exp Immunol 2006; 143: 305-313.
40. Ndumbi P, Gillis J, Raboud J etal. and The Canadian Observational Cohort (CANOC) collaboration. Clinical impact of altered T-cell homeostasis in treated HIV-infected patients enrolled in the Canadian Observational Cohort (CANOC). 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA, March 2013.
41. Labalette M, Salez F, Pruvot FR, Noel C, Dessaint JP. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol 1994; 95: 465-471.
42. Schroff RW, Gale RP, Fahey JL. Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol 1982; 129: 1926-1930.
43. Naeger DM, Martin JN, Sinclair E etal. Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS ONE 2010; 5: e8886.
44. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2001; 121: 187-201.
45. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 2004; 4: 607-613.
46. Sylwester AW, Mitchell BL, Edgar JB etal. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685.
47. Weinberger B, Lazuardi L, Weiskirchner I etal. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68: 86-90.
48. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4+T lymphocytopenia. Ann Intern Med 1993; 119: 55-62.